<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02946983</url>
  </required_header>
  <id_info>
    <org_study_id>S57996</org_study_id>
    <nct_id>NCT02946983</nct_id>
  </id_info>
  <brief_title>Influence of Intragastric Fructose Infusion on Behavioural and Neural Responses to Negative Emotion Induction</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitaire Ziekenhuizen Leuven</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universitaire Ziekenhuizen Leuven</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators will test whether a subliminal, intragastric dose of fructose is able to
      influence the emotional state at the behavioural and neural level, as has been previously
      shown for fatty acids. They will also examine the potential involvement of gut peptide
      release. Based on previous research using fatty acids, an attenuating effect of fructose
      compared to placebo on the induced negative emotional state is hypothesized at the
      self-report as well as the brain level.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2015</start_date>
  <completion_date type="Actual">June 2016</completion_date>
  <primary_completion_date type="Actual">June 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Functional brain images</measure>
    <time_frame>From the start of the study until the endpoint of the study, with a total duration of 50 minutes</time_frame>
    <description>Changes in brain responses after administration of our test solution compared to baseline will be assessed via functional magnetic resonance imaging</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Hunger scores</measure>
    <time_frame>every 10 minutes since the scan starts until 40 minutes after the start of the scan</time_frame>
    <description>The hunger scores will be taken every 10 minutes since the scan starts via a 10 cm visual analogue scale.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mood assessment via the Self Assessment Manikin questionnaire</measure>
    <time_frame>every 10 minutes since the scan starts until 40 minutes after the start of the scan</time_frame>
    <description>Mood will be assessed every 10 minutes since the scan starts via the Self Assessment Manikin questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Gut hormone levels</measure>
    <time_frame>every 10 minutes since the scan starts until 40 minutes after the start of the scan</time_frame>
    <description>Peripheral blood samples will be taken every 10 min since the scan starts until the endpoint of the study to measure gut hormones (motilin, ghrelin, CCK, PYY, GLP-1) by radioimmuno-assay.</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">15</enrollment>
  <condition>Healthy Volunteers</condition>
  <arm_group>
    <arm_group_label>Fructose - Neutral emotion condition</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Intragastric infusion of fructose with neutral emotion induction</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Fructose - Sad emotion condition</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Intragastric infusion of fructose with sad emotion induction</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo - Neutral emotion condition</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Intragastric infusion of distilled water with neutral emotion induction</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo - Sad emotion condition</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Intragastric infusion of distilled water with sad emotion induction</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Fructose</intervention_name>
    <description>Intragastric administration of fructose (25g dissolved in 250ml distilled water)</description>
    <arm_group_label>Fructose - Neutral emotion condition</arm_group_label>
    <arm_group_label>Fructose - Sad emotion condition</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Control</intervention_name>
    <description>Intragastric administration of distilled water</description>
    <arm_group_label>Placebo - Neutral emotion condition</arm_group_label>
    <arm_group_label>Placebo - Sad emotion condition</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy volunteers (N=15)

          -  Male and female

          -  Age 18 - 60

          -  Body Mass Index (BMI) of 20 - 25 kg/m2

          -  Stable body weight for at least 3 months prior to the start of the study

        Exclusion Criteria:

          -  Abdominal or thoracic surgery. Exception: appendectomy

          -  Gastrointestinal, endocrine or neurological diseases. Exception: IBS if the
             participant will be recruited in the patient group

          -  Cardiovascular, respiratory, renal or urinary diseases

          -  Hypertension

          -  Food or drug allergies

          -  Anemia

          -  Eating disorders

          -  Psychotic disorders

          -  Depressive disorders

          -  Emotional and/or restraint eating

          -  No medication on a regular basis, exception: oral contraception

          -  No history of cannabis use or any other drug of abuse for at least 12 months prior to
             the study

          -  Alcohol abuse (more than 21 units of alcohol for men, more than 14 units for woman per
             week)

          -  Conditions that can interfere with functional magnetic resonance imaging (fMRI), e.g.
             cochlear implants, metal fragments or metal implants in the body, pacemaker, neural
             stimulator, â€¦

          -  Pregnant or breastfeeding women

          -  Claustrophobia
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jan Tack, Prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Leuven</affiliation>
  </overall_official>
  <verification_date>May 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 12, 2016</study_first_submitted>
  <study_first_submitted_qc>October 26, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 27, 2016</study_first_posted>
  <last_update_submitted>October 26, 2016</last_update_submitted>
  <last_update_submitted_qc>October 26, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 27, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

